- Home
- EXAS vs TCBIO Comparison
EXAS vs TCBIO Comparison
Compare EXAS & TCBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- TCBIO
- Stock Information
- Founded
- EXAS 1995
- TCBIO N/A
- Country
- EXAS United States
- TCBIO United States
- Employees
- EXAS N/A
- TCBIO 1818
- Industry
- EXAS Medical Specialities
- TCBIO Major Banks
- Sector
- EXAS Health Care
- TCBIO Finance
- Exchange
- EXAS Nasdaq
- TCBIO Nasdaq
- Market Cap
- EXAS 10.7B
- TCBIO N/A
- IPO Year
- EXAS N/A
- TCBIO N/A
- Fundamental
- Price
- EXAS $56.28
- TCBIO $20.03
- Analyst Decision
- EXAS Strong Buy
- TCBIO
- Analyst Count
- EXAS 20
- TCBIO 0
- Target Price
- EXAS $70.68
- TCBIO N/A
- AVG Volume (30 Days)
- EXAS 3.6M
- TCBIO N/A
- Earning Date
- EXAS 07-30-2025
- TCBIO N/A
- Dividend Yield
- EXAS N/A
- TCBIO N/A
- EPS Growth
- EXAS N/A
- TCBIO N/A
- EPS
- EXAS N/A
- TCBIO N/A
- Revenue
- EXAS $2,828,128,000.00
- TCBIO N/A
- Revenue This Year
- EXAS $14.58
- TCBIO N/A
- Revenue Next Year
- EXAS $12.75
- TCBIO N/A
- P/E Ratio
- EXAS N/A
- TCBIO N/A
- Revenue Growth
- EXAS 11.57
- TCBIO N/A
- 52 Week Low
- EXAS $39.97
- TCBIO N/A
- 52 Week High
- EXAS $72.83
- TCBIO N/A
- Technical
- Relative Strength Index (RSI)
- EXAS 61.48
- TCBIO 52.74
- Support Level
- EXAS $55.26
- TCBIO $19.88
- Resistance Level
- EXAS $58.68
- TCBIO $20.27
- Average True Range (ATR)
- EXAS 1.98
- TCBIO 0.28
- MACD
- EXAS -0.14
- TCBIO 0.01
- Stochastic Oscillator
- EXAS 64.86
- TCBIO 57.89
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About TCBIO Texas Capital Bancshares Inc. Depositary Shares 5.75% Fixed Rate Non-Cumulative Perpetual Preferred Stock Series B
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment excluding mortgage finance loans and other national lines of business. The bank operates in Texas main metropolitan areas like Austin Dallas Fort Worth Houston and San Antonio.